Test Price
2,800 AED✅ Home Collection Available
Low-Input Eukaryotic mRNA Sequencing in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Diagnostic Accuracy: 99.9% diagnostic sensitivity via ISO 9001:2015 certified processing (certificate INT/EGQ/2509DA/3139). Low-input capability supports as little as 10 pg of total RNA with single-cell compatibility.
Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Guidance: Post-test telephonic consultation with a DHA-licensed Consultant Medical Genetics for result interpretation and personalised next-step planning.
Insurance Facilitation: Direct insurance coverage verification and pre-authorisation support via WhatsApp at +971 54 548 8731.
Data Compliance: All personal data processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical consent and safety procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Test Overview & Methodology
Low-Input Eukaryotic mRNA Sequencing is a high-resolution transcriptomic assay that captures the complete gene expression profile from minimal tissue, cells, or whole blood samples. This next-generation sequencing (RNA-seq) test unlocks molecular insights for oncology, anti-aging medicine, and translational research with exceptional sensitivity even from picogram-level RNA input. The assay employs Illumina NovaSeq technology with unique molecular identifiers (UMIs) and stranded library preparation to deliver strand-specific, digitally counted expression data with minimal bias.
| Feature | Our Test (Low-Input Eukaryotic mRNA Seq) | Closest Alternative (Conventional RNA-seq) |
|---|---|---|
| Precision / Sensitivity | 99.9% diagnostic sensitivity with as low as 10 pg input; single-cell compatible | Requires ≥100 ng total RNA; limited sensitivity for low-abundance transcripts |
| Methodology | Illumina NovaSeq RNA-seq with unique molecular identifiers (UMIs) and stranded library prep | Standard TruSeq library prep without UMI deduplication; strand-non-specific |
| Turnaround Time | 5 weeks from sample receipt | 6–8 weeks, often longer with low-quality samples |
Physician Insight & Safety Protocols
Dr. Lina Osama Zaki Quteineh (DHA License: 9294403 | Consultant Medical Genetics) shares:
This transcriptomic assay provides a genome-wide snapshot of gene activity at the mRNA level. Results must be interpreted within the full clinical context including histopathology, imaging, and laboratory findings. As a DHA-licensed Consultant Medical Genetics, I emphasise that differential expression patterns require orthogonal validation and confirmed clinical correlation before any therapeutic decisions are made. This test is a powerful adjunct to clinical assessment, not a standalone diagnostic tool.
Advisory: Medication Safety & Clinical Precautions
Do not discontinue any prescribed medication without consulting your treating physician. This test informs clinical decision-making but does not replace ongoing medical evaluation. All management changes must be made by your healthcare provider in consideration of your full medical history.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection or uncontrolled inflammation may alter gene expression profiles and should be clinically stabilised before sample collection.
- Severe immunosuppression or bone marrow failure states require specialist clearance prior to sampling.
- Pregnancy or breastfeeding without explicit specialist approval, as transcriptomic reference intervals have not been validated for these physiological states.
- Seek immediate medical attention if you experience sudden unexplained weight loss, severe pain, neurological deficits, or any acute deterioration while awaiting results. These symptoms are unrelated to the test procedure and require urgent clinical evaluation.
All clinical procedures are conducted in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the purpose of low-input eukaryotic mRNA sequencing?
It identifies gene expression patterns from minimal biological samples to guide precision oncology, anti-aging interventions, and biomarker discovery. By capturing the complete transcriptome, the test reveals which genes are turned on or off in your tissue, helping oncologists tailor targeted therapies and researchers validate molecular pathways—all from a tiny specimen that conventional methods cannot process.
2. How long does it take to receive results, and how are they delivered?
Results are issued within 5 weeks of sample receipt and delivered via a secure, encrypted digital report with integrated clinical interpretation. You will receive a comprehensive PDF report containing gene expression heatmaps, differential expression statistics, and a physician-oriented summary. Our telephonic post-test guidance session ensures you understand the findings and their clinical relevance before any next steps.
3. Is any special preparation needed before providing the sample?
No fasting or medication changes are required, but inform your ordering physician about all current supplements and treatments. For tissue or cells, your specialist will handle collection aseptically; for whole blood, our home phlebotomist uses a standard venipuncture protocol. Ensure you are well-hydrated and avoid heavy exercise 24 hours prior to blood draw to minimise transient expression changes.
4. How does this test differ from standard RNA sequencing offered elsewhere?
Our assay uses unique molecular identifiers (UMIs) and stranded library preparation, enabling accurate digital counting of transcripts and strand-specific expression analysis from as little as 10 pg of RNA. Conventional RNA-seq typically requires 100 ng or more of total RNA, lacks UMI-based error correction, and does not preserve strand information. This means our test delivers higher accuracy for low-abundance transcripts, better reproducibility across replicates, and fuller biological insight from limited specimens such as core needle biopsies or sorted cell populations.
UAE Regulatory & Data Privacy Adherence
Your data is protected under the highest standards of UAE law. All personal data processed for this test is handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical consent, safety, and liability are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE adheres strictly to these regulations to ensure your privacy and safety at every stage.
Clinical & Logistical Metadata
| Test Name | Low-Input Eukaryotic mRNA Sequencing |
| Price (AED) | 2800 AED |
| Turnaround Time | 5 weeks from sample receipt |
| Sample Type / Matrix | Tissue biopsy, sorted cells, whole blood (PAXgene or Tempus tube), cultured cells. Note: Tissue biopsy collection requires hospital setting; home phlebotomy available for whole blood only upon specialist request. |
| Methodology Used | Illumina NovaSeq RNA-seq with unique molecular identifiers (UMIs) and stranded library preparation |
| ICD-10-CM Code | Z01.818 — Encounter for other specified special examination |
| LOINC Code | 95826-3 — mRNA sequencing |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians